Andere talen Helix BioPharma Corp.

Aandelen

HBP

CA4229101098

Beurs gesloten - Toronto S.E. Andere beurzen 18:06:34 06-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,22 ^CAD	+7,32%		0,00%	+4,76%

14/02	Helix BioPharma Corp. Benoemt Praveen Varshney tot bedrijfssecretaris	CI
2023	Helix BioPharma Corp. Rapporteert winstresultaten voor het eerste kwartaal eindigend op 31 oktober 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Helix BioPharma Corp. announced that it has received CAD 1.915 million in funding	08/04
Canadian Investment Regulatory Organization Trade Resumption - HBP	01/04
Canadian Investment Regulatory Organization Trading Halt - HBP	28/03
Helix BioPharma Corp. announced that it expects to receive CAD 1.915 million in funding	28/03
North American Morning Briefing : Markets Steady -2-	26/03
Helix BioPharma Corp. Appoints Praveen Varshney as Corporate Secretary	14/02
Helix BioPharma Corp. Appoints Praveen Varshney as Chief Financial Officer	14/02
Helix BioPharma Corp. Reports Voting Results	18/01
North American Morning Briefing : S&P 500 Eyes Record High as Rate Cut Hopes Underpin Sentiment	19/12
Helix Biopharma: Fiscal Q1 Earnings Snapshot	15/12
Helix BioPharma Corp. Reports Earnings Results for the First Quarter Ended October 31, 2023	14/12
Helix BioPharma Corp. Announces Fiscal 2024 First Quarter Results	14/12
North American Morning Briefing : Traders Eye -2-	12/12
Helix BioPharma : Announces Closing of Private Placement of CAD $3 Million and Board Changes	02/11
Helix Biopharma: Fiscal Q4 Earnings Snapshot	28-10-23
Helix BioPharma Corp. Reports Earnings Results for the Full Year Ended July 31, 2023	28-10-23
Helix Biopharma Corp. Announces Fiscal 2023 Year-End Results	27-10-23
Helix BioPharma Corp. announced that it has received CAD 2.998 million in funding	27-10-23
Helix BioPharma Corp. to Present New Preclinical Data on L-DOS47 in Combination with PD1 Checkpoint Inhibitor at the 2023 AACR- NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics	11-10-23
Helix Biopharma Announces Upcoming Poster Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics	10-10-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Helix BioPharma Corp.

Aandelen

HBP

CA4229101098

Andere talen

Filters